Direktorat Registrasi ObatValid

DIGOXIN

BPOM Number: GKL2133552643A1
Approved: 6 September 2026
Expiry: 5 September 2031
Form: INJEKSI

About This Registration

DIGOXIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2133552643A1. Its current registration status is Valid, with the licence valid until 5 September 2031. The product is registered to NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA. BPOM first approved this registration in September 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 7 September 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 5 AMPUL @ 2 ML
Department: Direktorat Registrasi Obat
Data Last Updated: 7 September 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
KAB. BOGOR
NPWP: 010026805052000
owner
View profile →

Manufacturing Sites

NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
KAB. BOGOR
primary
View profile →

Ingredients (1)

DIGOXIN

Market Intelligence

Owner Portfolio: NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA holds 567 BPOM registrations
Manufacturer Scale: NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA produces 567 registered products
Update Status: Recently updated (17 days ago)

FDA Cross-Reference

via openFDA

Generic Name: DIGOXIN
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?